Literature DB >> 9620094

The organophosphate pesticide chlorpyrifos affects form deprivation myopia.

A M Geller1, A A Abdel-Rahman, R L Peiffer, M B Abou-Donia, W K Boyes.   

Abstract

PURPOSE: The effects of the anti-cholinesterase organophosphate pesticide chlorpyrifos (CPF) on the refractive development of the eye were examined. Form deprivation was used to induce eye growth to address the previously reported relationship between organophosphate pesticide use and the incidence of myopia.
METHODS: Chickens, a well-established animal model for experimental myopia and organophosphate neurotoxicity, were dosed with chlorpyrifos (3 mg/kg per day, orally, from day 2 to day 9 after hatching) or corn oil vehicle (VEH) with or without monocular form deprivation (MFD) over the same period. The set of dependent measures included the refractive state of each eye measured using retinoscopy, axial dimensions determined with A-scan ultrasound, and intraocular pressure.
RESULTS: Dosing with CPF yielded an inhibition of 35% butyrylcholinesterase in plasma and 45% acetylcholinesterase in brain. MFD resulted in a significant degree of myopia in form-deprived eyes resulting from significant lengthening of the vitreal chamber of the eye. CPF significantly reduced the effect of MFD, resulting in less myopic eyes (mean refraction: VEH-MFD = -16.2 +/- 2.3 diopters; CPF-MFD = -11.1 +/- 1.8 diopters) with significantly shorter vitreal chambers. Nonoccluded eyes were, on average, slightly hyperopic. Treatment with CPF for 1 week in the absence of MFD led to no significant change in ocular dimensions or refraction relative to controls.
CONCLUSIONS: The use of form deprivation as a challenge suggests that CPF treatment interferes with the visual regulation of eye growth.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9620094

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  Image defocus and altered retinal gene expression in chick: clues to the pathogenesis of ametropia.

Authors:  Richard A Stone; Alice M McGlinn; Donald A Baldwin; John W Tobias; P Michael Iuvone; Tejvir S Khurana
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-29       Impact factor: 4.799

2.  Pharmaceutical intervention for myopia control.

Authors:  Prema Ganesan; Christine F Wildsoet
Journal:  Expert Rev Ophthalmol       Date:  2010-12-01

Review 3.  Pharmacology of myopia and potential role for intrinsic retinal circadian rhythms.

Authors:  Richard A Stone; Machelle T Pardue; P Michael Iuvone; Tejvir S Khurana
Journal:  Exp Eye Res       Date:  2013-01-08       Impact factor: 3.467

4.  Hematobiochemical and pathological alterations due to chronic chlorpyrifos intoxication in indigenous chicken.

Authors:  Shameem Ara Begum; Tirtha Nath Upadhyaya; Taibur Rahman; Debesh Chandra Pathak; Kavita Sarma; Chandana Choudhury Barua; R S Bora
Journal:  Indian J Pharmacol       Date:  2015 Mar-Apr       Impact factor: 1.200

5.  How safe is the use of chlorpyrifos: Revelations through its effect on layer birds.

Authors:  P P Singh; Ashok Kumar; R S Chauhan; P K Pankaj
Journal:  Vet World       Date:  2016-07-22

6.  Paraoxonase enzyme protects retinal pigment epithelium from chlorpyrifos insult.

Authors:  Jagan Mohan Jasna; Kannadasan Anandbabu; Subramaniam Rajesh Bharathi; Narayanasamy Angayarkanni
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

7.  Insights into the mechanism by which atropine inhibits myopia: evidence against cholinergic hyperactivity and modulation of dopamine release.

Authors:  Kate Thomson; Tamsin Kelly; Cindy Karouta; Ian Morgan; Regan Ashby
Journal:  Br J Pharmacol       Date:  2021-10-10       Impact factor: 9.473

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.